ScripAs Menarini builds out its “glocalized” portfolio strategy to propel its business in the Asia-Pacific, the Italian group is also advancing efforts in digital innovation and leveraging real-world evide
ScripThe Menarini group is putting the pedal to the metal in the Asia Pacific region, with a “glocalised” approach that adapts its portfolio and pricing plank to the local market, funding and affordability
ScripHopes that Arvinas/Pfizer’s estrogen receptor-targeting protein degrader vepdegestrant will show improved efficacy in breast cancer over selective estrogen receptor degraders (SERDs) appear dimmer fol
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regenxbio Calls On Nippon Shinyaku To